Response to hepatitis B vaccine in alcoholics without clinically evident liver cirrhosis;Resposta à vacinação contra a hepatite B em alcoolistas sem cirrose hepática clinicamente evidente

Arquivos de Gastroenterologia

Volumn 44, Issue 3, 2007, Pages 195-200

  De Oliveira, Luiz Carlos Marques ^a,b   Da Silva, Taís Estevão ^a   Alves, Márcio Henrique ^a  

^a FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

^b NONE   (Brazil)

Author keywords

Alcoholism; Hepatitis B; Hepatitis B vaccines; Hepatitis B virus

Indexed keywords

HEPATITIS B ANTIBODY; RECOMBINANT HEPATITIS B VACCINE;

ADULT; ALCOHOL LIVER CIRRHOSIS; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; BODY MASS; CHRONIC PANCREATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DELTOID MUSCLE; DRINKING BEHAVIOR; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MALE; PANCREAS INSUFFICIENCY; SEROCONVERSION; VACCINATION;

EID: 36849048243     PISSN: 00042803     EISSN: 16784219     Source Type: Journal    
DOI: 10.1590/s0004-28032007000300003     Document Type: Article

References (44)

1. Basile A, Vitale G, Macor C. Hepatitis B virus infection in alcoholic cirrhosis. Br Med J. 1981;282:1705.
2. Brasil. Ministério da Saúde. Programa Nacional de Hepatites Virais. Hepatites virais. O Brasil está atento. Brasília DF, 2003.
3. Bréchot C, Nalpas B, Couroucé AM, Duhamel G, Callard P, Carnot F, Tiollais P, Berthelot P. Evidence that hepatitis B virus has a role in liver-cell carcinoma in alcoholic liver disease. N Engl J Med. 1982;306:1384-7.
4. Consenso Latino-Americano sobre obesidade. [online] Rio de Janeiro, Brasil, 1998. Disponível em: http://www.abeso.org.br/doc/consenso.doc
5. Cook RT. Alcohol abuse, alcoholism, and damage to the immune system - a review. Alcohol Clin Exp Res. 1998;22:1927-42.
6. Curciarello J, Apraiz M, Chiera A, Castelletto R, Vassia MA, Barbero R, Belloni P, Castelletto E, Jmelnitzkv A. Hepatitis B and C virus in chronic alcoholic patients: prevalence and influence on liver injury. Acta Gastroenterol Latinoam. 1996;26:211-4.
7. Degos F, Brechot C, Nalpas B, Duhamel G, Corouce AM, Tron F, Berthelot P. Hepatitis B vaccination and alcoholic cirrhosis. Lancet. 1983;2:1498.
8. Degos F, Duhamel G, Brechot C, Nalpas B, Courouce AM, Tron F, Berthelot P. Hepatitis B vaccination in chronic alcoholics. J Hepatol. 1986;2:402-9.
9. Ewing JA. Detecting alcoholism. The CAGE questionnaire. JAMA. 1984;252:1905-7.
10. Fiellin DA, Reid MC, O'Connor PG. Screening for alcohol problems in primary care: a systematic review. Arch Intern Med. 2000;160:1977-89.
11. Fisman DN, Agrawal D, Leder K. The effect of age on immunologic response to recombinant hepatitis B vaccine: a meta-analysis. Clin Infect Dis. 2002;35:1368-75.
12. Hall AJ. Hepatitis B vaccination: protection for how long and against what? Br Med J. 1993;307:276-7.
13. Hislop WS, Follett EAC, Bouchier IAD, MacSween RNM. Serological markers of hepatitis B in patients with alcoholic liver disease: a multi-centre survey. J Clin Pathol. 1981;34:1017-9.
14. Jerrells TR. Immunodeficiency associated with ethanol abuse. Adv Exp Med Biol. 1991;288:229-36.
15. Lai CL, Ratziu V, Yuen MF, Poynard T. Viral hepatitis B. Lancet. 2003;362:2089-94.
16. Laskus T, Lupa E, Babiuch L. Prevalence of hepatitis B virus markers among Polish alcoholics. Scand J Infect Dis. 1988;20:571-2.
17. Laskus T, Slusarczyk J, Lupa E, Cianciara J. Course and outcome of acute type B hepatitis in heavy alcohol abusers. Digestion. 1991;49:231-4.
18. Laskus T, Radkowski M, Lupa E, Horban A, Cianciara J, Slusarczyk J. Prevalence of markers of hepatitis viruses in out-patient alcoholics. J Hepatol. 1992;15:174-8.
19. McAleer WJ, Buynak EB, Maigetter RZ, Wampler DE, Miller WJ, Hilleman MR. Human hepatitis B vaccine from recombinant yeast. Nature. 1984;307:178-80.
20. McMahon BJ, Wainwright K, Bulkow L, Parkinson AJ, Lindenbaum M, Wainwright R, Helminiak C. Response to hepatitis B vaccine in Alaska natives with chronic alcoholism compared with non-alcoholic control subjects. Am J Med. 1990;88:460-4.
21. McMahon BJ. Epidemiology and natural history of hepatitis B. Semin Liver Dis. 2005;25 (suppl 1):3-8.
22. Maruyama N, Sata M, Ishii K, Atono Y, Ono K.; Matuda T, Suzuki H, Muraoka H, Nakano H, Hino K. et al. Hepatitis B vaccination in alcoholics. Kansenshogaku Zasshi. 1989;63:27-34.
23. Mendenhall C, Roselle GA, Lybecker LA, Marshall LE, Grossman CJ, Myre SA, Weesner RE, Morgan DD. Hepatitis B vaccination. Response of alcoholic with and without liver injury. Dig Dis Sci. 1988;33:263-9.
24. Mincis M, Guimarães RX, Farinazzo-Neto J, Novo NF, Chechter L. Marcadores imunológicos do vírus B da hepatite em alcoólatras e indivíduos normais. Rev Paul Med. 1984;102:205-13.
25. Naito K, Tsuji T, Nozaki H, Nagashima H. High prevalence of hepatitis B virus infection among heavy alcohol drinkers in Japan. Microbiol Immunol. 1977;21:735-8.
26. Nalpas B, Thepot V, Driss F, Pol S, Courouce AM, Saliou P, Berthelot P. Secondary immune response to hepatitis B virus vaccine in alcoholics. Alcohol Clin Exp Res. 1993;17:295-8.
27. Nalpas B, Pol S, Thepot V, Zylberbert H, Berthelot P, Brechot C. ESBRA 1997 Award lecture: relationship between excessive alcohol drinking and viral infections. Alcohol Alcohol. 1998;33:202-6.
28. Oliveira LCM, Buso AG, Oliveira ATR, Arantes CA, Borges LV, Valente SRG. Prevalence of hepatitis B and hepatitis C markers in alcoholics with and without clinically evident hepatic cirrhosis. Rev Inst Med Trop S Paulo. 1999;41:69-73.
29. Oliveira LCM, Pereira RG, Reis UC. Prevalence of human immunodeficiency virus infection in alcoholics. Mem Inst Oswaldo Cruz. 2001;96:21-3.
30. Orholm M, Aldershvile J, Tage-Jensen U, Schlichting P, Nielsen JO, Hardt F, Christoffersen P. Prevalence of hepatitis B virus infection among alcoholic patients with liver disease. J Clin Pathol. 1981;34:1378-80.
31. Saunders JB, Wodak AD, Morgan-Capner P, White YS, Portmann B, Davis M, Williams R. Importance of markers of hepatitis B virus in alcoholic liver disease. Br Med J. 1983;286:1851-4.
32. Silva LC, Carrilho FJ, França AVC. Profilaxia das hepatites por vírus. In: Silva LC, editor. Hepatites agudas e crônicas. São Paulo: Sarvier; 2003. p.334-44.
33. Stigendal L, Hermodsson S, Olsson R. Prevalence of markers of hepatotrophic viruses in alcoholics with symptomatic liver cirrhosis or pancreatitis. Scand J Gastroenterol. 1984;19:588-90.
34. Tolosa Martinez N, Tenias Burillo JM, Perez Bermudez B, Bautista Sanchis Alvarez J. Factors associated with inadequate response to hepatitis B vaccination in health care personnel. Rev Esp Salud Publica. 1998;72:509-15.
35. Villa E, Rubbiani L, Barchi T, Ferretti I, Grisendi A, De Palma M, Bellentani S, Manenti F. Susceptibility of chronic symptomless HBsAg carriers to ethanol-induced hepatic damage. Lancet. 1982;2:1243-4.
36. Villanueva C, Enriquez J, Just J, Teixido M, Mendez C, Rodrigo O. Vaccination against the hepatitis B virus in alcoholics. Med Clin (Barc). 1991;96:211-4.
37. Voltarelli JC, Falcão RP. Imunodeficiências secundárias. Medicina (Ribeirão Preto). 1995;28:329-77.
38. Yamanaka T, Shiraki K, Nakazaawa S, Okano H, Ito T, Deguchi M, Takase K, Nakano T. Impact of hepatitis B and C virus infection on the clinical prognosis of alcoholic liver cirrhosis. Anticancer Res. 2001;21:2937-40.
39. Yen YH, Chen CH, Wang JH, Lee CM, Changchien CS, Lu SN. Study of hepatitis B (HB) vaccine non-responsiveness among health care workers from an endemic area (Taiwan). Liver Int. 2005;25:1162-8.
40. Yu AS, Cheung RC, Keeffe EB. Hepatitis B vaccines. Infect Dis Clin North Am. 2006;20:27-45.
41. Winter AP, Follett EA, McIntyre J, Stewart J, Symington IS. Influence of smoking on immunological responses to hepatitis B vaccine. Vaccine 1994;12:771-2.
42. Wood RC, MacDonald KL, White KE, Hedberg CW, Hanson M, Osterholm MT. Risk factors for lack of detectable antibody following hepatitis B vaccination of Minnesota health care workers. JAMA. 1993;270:2935-9.
43. Wright TL. Introduction to chronic hepatitis B infection. Am J Gastroenterol. 2006;101 (Suppl 1):s1-s6.
44. Zuckerman JN. Protective efficacy, immunotherapeutic potential, and safety of hepatitis B vaccines. J Med Virol. 2006;78:169-77.